PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentCloning confusion in the US

BioNews

Cloning confusion in the US

Published 18 June 2009 posted in Comment and appears in BioNews 162

Author

Dr Jess Buxton

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).

In March of this year, scientists in the UK were finally given the go-ahead to begin research aimed at developing new disease treatments using cells extracted from early human embryos Ð therapeutic cloning. It took nearly three years of parliamentary and public debate to put the necessary regulatory framework in place...

In March of this year, scientists in the UK were finally given the go-ahead to begin research aimed at developing new disease treatments using cells extracted from early human embryos - therapeutic cloning. It took nearly three years of parliamentary and public debate to put the necessary regulatory framework in place, which included an amendment to the Human Fertilisation and Embryology Act of 1990. As we report in this week's BioNews, the introduction of new cloning legislation in the US looks set to be a similarly long and drawn-out process.

Since the technology was first developed, US research into the cloning of human embryos has continued unregulated in the private sector, whilst government-funded scientists are banned from such work. Senators were shortly expected to vote on two rival bills that aimed to introduce new legislation to address this situation. The first of these, passed by Congress last year, called for a total ban on all forms of cloning, whether for reproductive or medical research purposes. The other sought to ban reproductive cloning whilst allowing research into therapeutic cloning to continue.


Despite repeated calls from President Bush for the Senate to support a complete cloning ban, intense lobbying by patient groups, scientists and biotech companies appears to have paid off. Following a series of amendments and procedural disputes last week, the bill that would have outlawed any cloning research was eventually withdrawn. It is not now clear when, or how the Senate will be considering the cloning issue.


So for now, it appears that human embryo stem cell research is a line of inquiry that could remain open to US scientists. However, the introduction of new cloning legislation may still be some way off. Some supporters of therapeutic cloning research now fear that this uncertainty may stop US scientists from embarking on research that may one day be criminalised. Millions of families affected by life-threatening illnesses, who might benefit from therapeutic cloning research, are aware that medical research into new treatments takes many years. Many US patients must now be hoping their politicians will not make them wait any longer than is absolutely necessary.

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Should egg and sperm donors remain anonymous?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Recent
4 July 2022 • 4 minutes read

Widening the debate about direct-to-consumer genetic testing and donor conception

4 July 2022 • 3 minutes read

Join PET and Genomics England to celebrate the 200th birthday of Gregor Mendel

27 June 2022 • 4 minutes read

Thirty years of PET: our 'Fertility, Genomics and Embryo Research' report

27 June 2022 • 5 minutes read

Children's rights and donor conception: What next?

20 June 2022 • 4 minutes read

The problems with lifting donor anonymity earlier

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856